PLATO: Ticagrelor Associated with Reduced Outcomes, Mortality in Patients with ACS

Cardiology Today -- Patients with acute coronary syndromes for whom an early invasive strategy was planned tended to benefit from ticagrelor and did not have an increase in bleeding, results from a study suggested.